Sea cucumber protein used to inhibit development of malaria parasite

December 26, 2007

Scientists have genetically engineered a mosquito to release a sea-cucumber protein into its gut which impairs the development of malaria parasites, according to research out today (21 December) in PLoS Pathogens. Researchers say this development is a step towards developing future methods of preventing the transmission of malaria.

Malaria is caused by parasites whose lives begin in the bodies of mosquitoes. When mosquitoes feed on the blood of an infected human, the malaria parasites undergo complex development in the insect’s gut. The new study has focused on disrupting this growth and development with a lethal protein, CEL-III, found in sea cucumbers, to prevent the mosquito from passing on the parasite.

Human blood infected with malaria contains parasitic gametocytes – cells which can create parasite sperm and eggs in the gut of the insect. These then fertilise, kick-starting the parasite reproductive process and life cycle by producing invasive offspring called ookinetes.

These ookinetes then migrate through the mosquito’s stomach wall and produce thousands of ‘daughter’ cells known as sporozoites. After 10-20 days these are ready in the salivary glands to infect another human when the mosquito takes a subsequent blood meal.

The international team fused part of the sea cucumber lectin gene with part of a mosquito gene so that the mosquito would release lectin into its gut during feeding. The released lectin is toxic to the ookinete and therefore kills the parasite in the mosquito’s stomach.

In laboratory tests the research team showed that introducing lectin to the mosquito’s gut in this way significantly impaired the development of malaria parasites inside the mosquito, potentially preventing transmission to other people. Early indications suggest that this sea cucumber protein could be effective on more than one of the four different parasites that can cause malaria in humans.

Professor Bob Sinden from Imperial College London’s Department of Life Sciences, one of the authors on the paper said: “These results are very promising and show that genetically engineering mosquitoes in this way has a clear impact on the parasites’ ability to multiply inside the mosquito host.”

However, Professor Sinden explains that there is still a lot of work to do before such techniques can be used to combat the spread of malaria in real-world scenario. This is because although the sea cucumber protein significantly reduces the number of parasites in mosquitoes, it does not totally remove all parasites from all mosquitoes and as such, at this stage of development, would not be effective enough to prevent transmission of malaria to humans.

Professor Sinden says he hopes studies such as this one, which improve scientists’ understanding of the complex process by which malaria parasites are transmitted, will lead to new advances in the quest to prevent malaria.

“Ultimately, one aim of our field is to find a way of genetically engineering mosquitoes so that the malaria parasite cannot develop inside them. This study is one more step along the road towards achieving that goal, not least because it has been shown that more than one species of malaria can be killed in this way.”

About 40% of the world’s population are at risk of malaria. Of these 2.5 billion people at risk, more than 500 million become severely ill with malaria every year and more than 1 million die from the effects of the disease.

Malaria is especially a serious problem in Africa, where one in every five childhood deaths is due to the effects of the disease. An African child has on average between 1.6 and 5.4 episodes of malaria fever each year.

Citation: Yoshida S, Shimada Y, Kondoh D, Kouzuma Y, Ghosh AK, et al. (2007) Hemolytic C-type lectin CEL-III from sea cucumber expressed in transgenic mosquitoes impairs malaria parasite development. PLoS Pathog 3(12): e192. doi:10.1371/journal.ppat.0030192 (www.plospathogens.org)

Source: Public Library of Science

Explore further: Scientists combine antimalarial drug with light sensitive molecules for promising treatment of cancer

Related Stories

Scientists combine antimalarial drug with light sensitive molecules for promising treatment of cancer

September 18, 2017
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment. Scientists from the National University of Singapore (NUS) recently showed that its anti-cancer properties could ...

Promising clinical trial results could give doctors a new tool against drug-resistant strains of malaria parasite

September 13, 2017
Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published in the latest issue of The Lancet Infectious ...

As 'flesh-eating' Leishmania come closer, a vaccine against them does, too

September 13, 2017
Parasites that ulcerate the skin, can disfigure the face, and may fatally mutilate its victim's internal organs are creeping closer to the southern edges of the United States.

PATH and WRAIR announce largest-ever controlled malaria infection

September 8, 2017
PATH's Malaria Vaccine Initiative (MVI) and the US Department of Defense's Walter Reed Army Institute of Research (WRAIR) announced today that vaccinations are under way in a clinical trial to evaluate modifications to the ...

New strategy for vaccinating pregnant mothers against malaria holds promise for protecting infants

September 5, 2017
A mother and infant in Malawi have the same repertoire of antibodies to Plasmodium falciparum, the malaria parasite. That suggests that boosting the mother's immune response to malaria, as via vaccination, will result in ...

Placenta-on-a-chip: Microsensor simulates malaria in the womb to develop treatments

August 29, 2017
Malaria, one of the most severe public health problems, affected 212 million people worldwide in 2015. This life-threatening disease is caused by parasites that are transmitted to humans through the bites of infected female ...

Recommended for you

Thousands of new microbial communities identified in human body

September 20, 2017
A new study of the human microbiome—the trillions of microbial organisms that live on and within our bodies—has analyzed thousands of new measurements of microbial communities from the gut, skin, mouth, and vaginal microbiome, ...

Study finds immune system is critical to regeneration

September 20, 2017
The answer to regenerative medicine's most compelling question—why some organisms can regenerate major body parts such as hearts and limbs while others, such as humans, cannot—may lie with the body's innate immune system, ...

Immune cells produce wound healing factor, could lead to new IBD treatment

September 20, 2017
Specific immune cells have the ability to produce a healing factor that can promote wound repair in the intestine, a finding that could lead to new, potential therapeutic treatments for inflammatory bowel disease (IBD), according ...

As men's weight rises, sperm health may fall

September 20, 2017
(HealthDay)—A widening waistline may make for shrinking numbers of sperm, new research suggests.

New model may help science overcome the brain's fortress-like barrier

September 19, 2017
Scientists have helped provide a way to better understand how to enable drugs to enter the brain and how cancer cells make it past the blood brain barrier.

Cell-based therapy success could be boosted by new antioxidant

September 19, 2017
Cell therapies being developed to treat a range of conditions could be improved by a chemical compound that aids their survival, research suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.